Global Pharmaceutical CDMO Competitive Landscape Professional Research Report 2025
Delivery：Within 72h| Full Report Selling Price |
|---|
3500.00 USD |
5250.00 USD |
7000.00 USD |
| Buy NowContact Us |
| Competitor Data Selling Price |
|---|
1000.00 USD |
1500.00 USD |
2000.00 USD |
| Buy NowContact Us |
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Pharmaceutical CDMO market size will reach 167,817 Million USD in 2025 and is projected to reach 274,274 Million USD by 2032, with a CAGR of 7.27% (2025-2032). Notably, the China Pharmaceutical CDMO market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A Pharmaceutical Contract Development and Manufacturing Organization (CDMO) is a specialized service provider that offers comprehensive support to pharmaceutical and biotechnology companies in the development, manufacturing, and commercialization of drug products. CDMOs serve as strategic partners, providing expertise and infrastructure for various stages of the drug development process, including formulation development, analytical testing, clinical trial manufacturing, and commercial-scale production. These organizations play a crucial role in the pharmaceutical industry by offering flexible and cost-effective solutions, enabling companies to outsource specific aspects of their drug development and manufacturing processes. Pharmaceutical CDMOs contribute to accelerating time-to-market, reducing development costs, and ensuring compliance with regulatory standards, allowing pharmaceutical companies to focus on research, innovation, and core competencies.
The major global suppliers of Pharmaceutical CDMO include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics, AMRI, Famar, WuXi Biologics, Asymchem, Zhejiang Jiuzhou Pharmaceutical, Apeloa Pharmaceutical, Porton Pharma, Amatsigroup, Fujifilm Diosynth, Biotechnologies, PCI Pharma Services, Pfizer CentreOne, Samsung Biologics, AGC Biologics, Divi＇s Laboratories Ltd, Piramal Pharma Solutions, Syngene International Ltd, Aragen Life Sciences, Akums Drugs and Pharmaceuticals, IDT Australia, Mayne Pharma, BioCina, Southern RNA, PharmSky Research, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Pharmaceutical CDMO. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Pharmaceutical CDMO market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Pharmaceutical CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pharmaceutical CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Pharmaceutical CDMO Include:
Lonza
Catalent
Patheon (Thermo Fisher Scientific)
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics
AMRI
Famar
WuXi Biologics
Asymchem
Zhejiang Jiuzhou Pharmaceutical
Apeloa Pharmaceutical
Porton Pharma
Amatsigroup
Fujifilm Diosynth
Biotechnologies
PCI Pharma Services
Pfizer CentreOne
Samsung Biologics
AGC Biologics
Divi＇s Laboratories Ltd
Piramal Pharma Solutions
Syngene International Ltd
Aragen Life Sciences
Akums Drugs and Pharmaceuticals
IDT Australia
Mayne Pharma
BioCina
Southern RNA
PharmSky Research
Pharmaceutical CDMO Product Segment Include:
Solid Formulation
Semi-solid Formulation
Liquid Formulation
Gas Formulation
Pharmaceutical CDMO Product Application Include:
Chemical Pharmaceutical
Biopharmaceutical
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Pharmaceutical CDMO Industry PESTEL Analysis
Chapter 3: Global Pharmaceutical CDMO Industry Porter’s Five Forces Analysis
Chapter 4: Global Pharmaceutical CDMO Major Regional Market Size and Forecast Analysis
Chapter 5: Global Pharmaceutical CDMO Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Pharmaceutical CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Pharmaceutical CDMO Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Global Pharmaceutical CDMO Revenue and Market Share by Player
| Revenue (US$ Million) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Lonza | XX | XX | XX | XX | XX |
| Catalent | XX | XX | XX | XX | XX |
| Patheon (Thermo Fisher Scientific) | XX | XX | XX | XX | XX |
| Aenova | XX | XX | XX | XX | XX |
| Siegfried | XX | XX | XX | XX | XX |
| Recipharm | XX | XX | XX | XX | XX |
| Strides Shasun | XX | XX | XX | XX | XX |
| Piramal | XX | XX | XX | XX | XX |
| Metrics | XX | XX | XX | XX | XX |
| AMRI | XX | XX | XX | XX | XX |
| Famar | XX | XX | XX | XX | XX |
| WuXi Biologics | XX | XX | XX | XX | XX |
| Asymchem | XX | XX | XX | XX | XX |
| Zhejiang Jiuzhou Pharmaceutical | XX | XX | XX | XX | XX |
| Apeloa Pharmaceutical | XX | XX | XX | XX | XX |
| Porton Pharma | XX | XX | XX | XX | XX |
| Amatsigroup | XX | XX | XX | XX | XX |
| Fujifilm Diosynth | XX | XX | XX | XX | XX |
| Biotechnologies | XX | XX | XX | XX | XX |
| PCI Pharma Services | XX | XX | XX | XX | XX |
| Pfizer CentreOne | XX | XX | XX | XX | XX |
| Samsung Biologics | XX | XX | XX | XX | XX |
| AGC Biologics | XX | XX | XX | XX | XX |
| Divi＇s Laboratories Ltd | XX | XX | XX | XX | XX |
| Piramal Pharma Solutions | XX | XX | XX | XX | XX |
| Syngene International Ltd | XX | XX | XX | XX | XX |
| Aragen Life Sciences | XX | XX | XX | XX | XX |
| Akums Drugs and Pharmaceuticals | XX | XX | XX | XX | XX |
| IDT Australia | XX | XX | XX | XX | XX |
| Mayne Pharma | XX | XX | XX | XX | XX |
| BioCina | XX | XX | XX | XX | XX |
| Southern RNA | XX | XX | XX | XX | XX |
| PharmSky Research | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
Related Report
Global Dydrogesterone Drug Competitive Landscape Professional Research Report 2025
Global Dydrogesterone Drug Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Global Olanzapine Competitive Landscape Professional Research Report 2025
Global Olanzapine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Global Oligonucleotide Pool Library Competitive Landscape Professional Research Report 2025
Global Oligonucleotide Pool Library Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Global Oligonucleotide Therapeutics Competitive Landscape Professional Research Report 2025
Global Oligonucleotide Therapeutics Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Order Process
Contact
1. Fill in your contact information, and the company will quickly match the specialist to get in touch with you
2. You can also directly call our customer service hotline or add customer service WeChat
Samples
1. One on one business specialist will send the complete version of the sample
2. If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples
Payment
1. Both parties sign a report purchase contract
2. Support Paypal, Visa, UnionPay and MasterCard Payment
Delivery
1. PDF report (sent online 2-3 working days after payment)
2. WORD version report (sent online 2-3 working days after payment)
3. Paper version report (sent via EMS or DHL within 3-5 working days after payment)
After-Sales
Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied
